Compare Adaptive Biotechnologies Corp (ADPT) vs Eli Lilly And Co (LLY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Eli Lilly And Co — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while Eli Lilly And Co trades at $1,216.5 (market cap $1.10T). The key difference: Eli Lilly And Co is far larger — about 330.3× Adaptive Biotechnologies Corp's market cap, and Eli Lilly And Co pays a 0.56% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | LLY | |
|---|---|---|
Market Cap | $3.33B | $1.10T |
Sector | Health | Health |
52-Week High | $22.37 | $1.24K |
52-Week Low | $10.24 | $625.65 |
Enterprise Value | $3.19B | $1.14T |
Dividend Yield | — | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
